Correlation Between Dianthus Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Dianthus Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Puma Biotechnology.
Diversification Opportunities for Dianthus Therapeutics and Puma Biotechnology
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dianthus and Puma is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Puma Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 1.33 times less risky than Puma Biotechnology. The stock trades about -0.05 of its potential returns per unit of risk. The Puma Biotechnology is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 299.00 in Puma Biotechnology on September 15, 2024 and sell it today you would lose (11.00) from holding Puma Biotechnology or give up 3.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dianthus Therapeutics vs. Puma Biotechnology
Performance |
Timeline |
Dianthus Therapeutics |
Puma Biotechnology |
Dianthus Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dianthus Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Dianthus Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.Dianthus Therapeutics vs. Biglari Holdings | Dianthus Therapeutics vs. SunOpta | Dianthus Therapeutics vs. Ryman Hospitality Properties | Dianthus Therapeutics vs. Ark Restaurants Corp |
Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |